Centre for Commercialization of Regenerative Medicine

Q: How much funding can be received?

There is no informations about how much funding can be received.

Q: What is the deadline to apply?

The deadline to apply is not specified.

Q: Is the Centre for Commercialization of Regenerative Medicine a grant, loan, or tax credit?

Centre for Commercialization of Regenerative Medicine is a Partnering and Collaboration

Q: Who are the financial supporters of the Centre for Commercialization of Regenerative Medicine?

Centre for Commercialization of Regenerative Medicine is funded by Centre for Commercialization of Regenerative Medecine

Q: Who can I contact for more information about the Centre for Commercialization of Regenerative Medicine?

You can contact Centre for Commercialization of Regenerative Medecine.

Q: Where is the Centre for Commercialization of Regenerative Medicine available?

The Centre for Commercialization of Regenerative Medicine program is available the province of ON.

Q: Are startups eligible for the Centre for Commercialization of Regenerative Medicine program?

Yes, startups are eligible to apply for the Centre for Commercialization of Regenerative Medicine program.

Last Update: July 22, 2025

ON, Canada

Help to commercialize cell and gene therapies and regenerative medicine technologies

At a glance

Eligible Funding

No Condition

Timeline

Unspecified

Financing Type

Partnering and Collaboration

Eligible Industries

Manufacturing

Funds Providers

Unspecified

Program status

Open

Overview

Access business services, regulatory expertise, technical services and a 40,000 square foot custom built facility for cell and gene therapy manufacturing in Toronto.

Activities funded

This grant is focused on supporting the commercialization of regenerative medicine technologies by bridging the gap between academia and industry. It aims to address manufacturing challenges and enable the development, scaling, and execution of regenerative medicine projects.

Assistance with process development and analytics for regenerative medicine innovations.
Pre-clinical to commercial GMP-compliant manufacturing services for cell and gene therapies.
Utilization of enabling technologies through industry partnerships to facilitate project development.
Collaboration on unique intracellular delivery platforms for ex vivo cell-based therapies.
Access to specialized infrastructure including Process Development Labs and GMP Clean Rooms.
Support for comprehensive development and manufacturing plans tailored to specific project needs.

Examples of admissible projects:

$ 875,000

Pilot clinical trial for new cell therapy at the Toronto manufacturing facility

$ 550,000

Design a software platform for cell therapy logistics at the Toronto facility

$ 1,000,000

Create a bioreactor to scale-up gene therapy production at the Toronto facility

$ 475,000

Launch a training program for gene therapy manufacturing at the Toronto facility

$ 600,000

Establish a regulatory consultation service for gene therapy startups in the Toronto facility

$ 750,000

Develop a cell therapy for chronic illnesses by using a custom-built facility

Eligibility

Eligibility criteria for this grant:

Applicants must be companies operating at the interface between academia and industry.
Projects must involve manufacturing challenges in areas like process development, analytics, and commercial GMP-compliant manufacturing.
Preference given to projects in cell and gene therapies, with a focus on advancing therapies towards the clinic.

Who is eligible?

The context provided does not detail specific eligibility criteria for a grant application directly related to CCRM's services. However, typically, the type of entities that may be interested in reaching out or exploring collaboration with CCRM include companies or research entities at the interface of academia and industry that are focused on cell and gene therapy manufacturing, require process development, and are aiming to transition from pre-clinical to GMP-compliant manufacturing stages. These may include small biotechs, large pharmaceutical companies, or research organizations involved in developing innovative therapies. Prospective partners are likely engaged in:- Manufacturing challenges needing technical support or solutions.- Cell and gene therapy development.- Seeking to scale from pre-clinical to commercial manufacturing.- Engaging in collaborative processes for technological and manufacturing development.- Needing infrastructure and resources for GMP-compliance and process continuity from lab to market.

Eligible expenses

The activities eligible for this grant are focused on addressing manufacturing challenges and advancing manufacturing processes for cell and gene therapies. This involves collaboration and utilization of specialized infrastructure and technologies to streamline production and ensure compliance with industry standards.

Tackling manufacturing challenges at the interface between academia and industry.
Accessing process development and analytics services for cell and gene therapies.
Availing pre-clinical to commercial GMP-compliant manufacturing services.
Collaborating with an industry-leading team, including 55+ PhDs, for specialized expertise.
Using enabling technologies through industry partnerships for advanced manufacturing solutions.

Selection criteria

There are evaluation and selection criteria for this grant. The criteria include:

Technical expertise and alignment with project goals
Demonstrated collaborative approach to problem-solving
Potential for successful process development and manufacturing
Track record of delivering complex projects on time and on budget

How to apply

Identification of the grant

Search for available grants that match the project
Read and understand the eligibility criteria
Ensure that the company/project meets the required criteria

Preparation of documentation

Gather all necessary information about the project
Collect the required financial documents
Prepare letters of support or recommendation
Write the project or business plan

Writing the application

Fill in the application forms accurately
Tailor the project to the issues and objectives of the grant
Ensure compliance of the provided information
Proofread and verify the spelling and accuracy of the information

Submission of the application

Check all documents and the application for completeness
Submit the application via the recommended online platform or by mail, according to the instructions
Receive confirmation of submission

Follow-up after submission

Note the submission date and response deadlines
Be prepared to provide additional information if requested
Monitor the progress of the application directly with the organization if possible

Additional information

Here are additional relevant details for this grant:

The collaboration with CCRM provides access to 55+ PhDs, ensuring significant specialized expertise to support projects.
CCRM boasts state-of-the-art facilities that are accessible for remote viewing, which can provide potential applicants with an insight into the possibilities for their projects.
CCRM has a strong track record, having supported three IND filings since 2019, indicating a proven capacity to aid in regulatory processes.
The collaboration with CCRM includes co-located process development and GMP-compliant manufacturing, ensuring seamless transition and process continuity from lab development to full-scale production.
Customer testimonials showcase successful collaborations, reflecting CCRM's effectiveness in improving manufacturing timelines and processes.

Apply to this program

Frequently Asked Questions about the Centre for Commercialization of Regenerative Medicine Program

Here are answers to the most common questions about the Centre for Commercialization of Regenerative Medicine. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the Centre for Commercialization of Regenerative Medicine?

How much funding can be received?

What is the deadline to apply?

Is the Centre for Commercialization of Regenerative Medicine a grant, loan, or tax credit?

Who are the financial supporters of the Centre for Commercialization of Regenerative Medicine?

Who is eligible for the Centre for Commercialization of Regenerative Medicine program?

To be eligible for the Centre for Commercialization of Regenerative Medicine program, you must: Companies must be involved in the commercialization of regenerative medicine technologies. Applicants are expected to collaborate with CCRM as an extension of their team to address manufacturing challenges. Projects should involve process development, analytics, or GMP-compliant manufacturing services.